We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$39.1B
1-Year Est. Return
28.69%
This Fund
S&P 500
This Quarter
Est. Return
+2.03%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$29.6B
AUM Growth
+$2.09B
(+7.6%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
6.41%
Top 10 Holdings %
Top 10 Hldgs %
35.06%
Holding
589
New
76
Increased
233
Reduced
176
Closed
64
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$275M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$244M |
| 3 |
Johnson & Johnson
JNJ
|
+$178M |
| 4 |
PR
Permian Resources
PR
|
+$176M |
| 5 |
Hilton Worldwide
HLT
|
+$140M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$171M |
| 2 |
Amazon
AMZN
|
+$106M |
| 3 |
TSMC
TSM
|
+$90.2M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$72.5M |
| 5 |
GE Aerospace
GE
|
+$65.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.91% |
| 2 | Healthcare | 22.8% |
| 3 | Financials | 10.47% |
| 4 | Communication Services | 9.58% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Haverty Furniture Companies
HVT
$416M
| $325K | ﹤0.01% |
12,852
-3,332
| -21% | -$96.2K |
|
477
G-III Apparel Group
GIII
$1.54B
| $324K | ﹤0.01% |
11,956
+1,863
| +18% | +$52.2K |
|
478
Target
TGT
$67.8B
| $323K | ﹤0.01% |
2,185
-699
| -24% | -$110K |
|
479
Haleon
HLN
$43.2B
| $318K | ﹤0.01% |
38,508
+9,974
| +35% | +$83.4K |
|
480
East-West Bancorp
EWBC
$18.1B
| $305K | ﹤0.01% |
4,170
+35
| +0.8% | +$2.6K |
|
481
Universal Health Services
UHS
$10.2B
| $300K | ﹤0.01% |
1,621
-3,837
| -70% | -$679K |
|
|
HSII
482
DELISTED
Heidrick & Struggles
HSII
| $299K | ﹤0.01% |
9,471
| – | – |
|
483
Vontier
VNT
$4.62B
| $295K | ﹤0.01% |
+7,722
| New | +$311K |
|
484
Popular Inc
BPOP
$11.1B
| $289K | ﹤0.01% |
+3,269
| New | +$284K |
|
485
Bread Financial
BFH
$4.48B
| $286K | ﹤0.01% |
+6,415
| New | +$252K |
|
486
Cimpress
CMPR
$2.4B
| $281K | ﹤0.01% |
3,205
+331
| +12% | +$28.8K |
|
487
Enel Chile
ENIC
$6.24B
| $275K | ﹤0.01% |
98,255
-51,450
| -34% | -$152K |
|
488
Enact Holdings
ACT
$6.68B
| $275K | ﹤0.01% |
+8,958
| New | +$273K |
|
489
Diageo
DEO
$49.2B
| $270K | ﹤0.01% |
2,143
| – | – |
|
490
VICI Properties
VICI
$29.2B
| $266K | ﹤0.01% |
9,295
| – | – |
|
491
Bankunited
BKU
$3.4B
| $264K | ﹤0.01% |
+9,023
| New | +$251K |
|
492
Sylvamo
SLVM
$1.52B
| $260K | ﹤0.01% |
+3,796
| New | +$250K |
|
493
AZZ Inc
AZZ
$4.48B
| $260K | ﹤0.01% |
+3,370
| New | +$263K |
|
494
Independent Bank Corp
IBCP
$793M
| $258K | ﹤0.01% |
9,574
| – | – |
|
495
Kulicke & Soffa
KLIC
$4.72B
| $256K | ﹤0.01% |
5,212
+827
| +19% | +$38.9K |
|
496
MakeMyTrip
MMYT
$5.81B
| $254K | ﹤0.01% |
3,018
-3,898
| -56% | -$291K |
|
497
Park Hotels & Resorts
PK
$3.04B
| $247K | ﹤0.01% |
16,500
-11,344
| -41% | -$182K |
|
498
Movado Group
MOV
$866M
| $247K | ﹤0.01% |
9,932
| – | – |
|
499
Photronics
PLAB
$1.85B
| $236K | ﹤0.01% |
9,551
+864
| +10% | +$23.4K |
|
500
Xerox
XRX
$411M
| $230K | ﹤0.01% |
19,827
-4,573
| -19% | -$66.4K |
|
Similar funds
HF
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2024 Portfolio in Review
As of Q2 2024, Grantham, Mayo, Van Otterloo & Co (GMO) held 589 positions worth $29.6B, up 7.6% from $27.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO) deployed $1.9B of net new capital in Q2 2024, opening 76 new positions and adding to 233 existing holdings. Its largest new stake was Thermo Fisher Scientific: 425,639 shares worth $235M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $171M trimmed.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2024 buy was Thermo Fisher Scientific: 425,639 shares worth $235M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Apple in Q2 2024, an estimated $275M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2024 reduction was Eli Lilly, cutting an estimated $171M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $72.5M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 35% of its $29.6B portfolio in Q2 2024.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 76 new positions and closed 64 in Q2 2024.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 7.6% quarter-over-quarter to $29.6B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2024, filed 13 Aug 2024.